Risk of Squamous Cell Carcinoma on Skin Areas Treated With Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5%

Clinical trial NCT01926496 · COMPLETED

Trial details

NCT number: NCT01926496
Sponsor: LEO Pharma
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Actinic Keratosis (AK)

Start date: 2013-09-11
Primary completion: 2019-07-11
Enrollment: 485

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.